Multiplex sequence-specific polymerase chain reaction reveals new MASP2 haplotypes associated with MASP-2 and MAp19

A B W Boldt1, C Grisbach, R Steffensen

  • 1Department of Medical Pathology, Hospital de Clínicas, Federal University of Paraná, Curitiba, Brazil.

Human Immunology
|June 21, 2011
PubMed

Insights

Investigating mannan-binding lectin-associated serine protease 2 (MASP-2) haplotypes using multiplex PCR-SSP reveals associations with MASP-2 levels. This rapid screening method can identify individuals at risk for MASP-2 related infections or inflammatory disorders.

Area of Science:

  • Immunogenetics
  • Molecular Biology
  • Human Genetics

Background:

  • Mannan-binding lectin-associated serine protease 2 (MASP-2) deficiency is linked to infections, while high levels correlate with inflammatory disorders.
  • MASP2 haplotypes, crucial for understanding MASP-2 regulation, have been underexplored due to complex and costly haplotyping methods.

Purpose of the Study:

  • To develop a cost-effective and time-efficient multiplex PCR-SSP method for MASP2 haplotyping.
  • To investigate the phylogenetic relationships and global distribution of identified MASP2 haplotypes.
  • To associate specific MASP2 haplotypes with MASP-2 and MAp19 plasma levels.

Main Methods:

  • Developed multiplex PCR with sequence-specific primers (PCR-SSP) for 8 single nucleotide polymorphisms (SNPs) in the MASP2 gene, reducing reactions from 18 to 7.
  • Evaluated phylogenetic relationships and global distribution of 10 identified haplotypes in Danish and South Brazilian populations.
  • Correlated identified haplotypes with MASP-2 and MAp19 plasma levels using statistical analysis.

Main Results:

  • Identified 10 MASP2 haplotypes, with four associated with reduced plasma MASP-2 levels (<200 ng/mL).
  • An intron 9 mutation was significantly associated with both high MASP-2 (>600 ng/mL) and low MAp19 (<200 ng/mL) levels (Kruskal-Wallis p < 0.0001).
  • Genotype frequencies predict approximately 0.4% severely deficient and 25% overproducing individuals in both studied populations.

Conclusions:

  • The developed multiplex MASP2 PCR-SSP is a rapid and low-cost screening tool.
  • This method can identify individuals with specific MASP-2 or MAp19 levels relevant to disease.
  • Early identification may facilitate therapeutic and preventive strategies for MASP-2 related conditions.